z-logo
open-access-imgOpen Access
753 G/A polymorphism of TLR2 in the susceptibility to pulmonary tuberculosis in the Lur population of Iran
Author(s) -
Farhad Shahsavar,
Gholamreza Shahsavari,
Alireza Azargoon
Publication year - 2016
Publication title -
asian pacific journal of tropical disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.208
H-Index - 33
ISSN - 2222-1808
DOI - 10.1016/s2222-1808(15)61046-5
Subject(s) - genotyping , odds ratio , genotype , tuberculosis , medicine , tlr2 , polymorphism (computer science) , immunology , gastroenterology , population , allele frequency , biology , genetics , tlr4 , receptor , pathology , gene , environmental health
Objective: To investigate whether 677 C/T toll like receptor 2 (TLR2) (Arg677Trp), 753 G/A\udTLR2 (Arg753Gln), 299 A/G TLR4 (Asp299Gly) and 399 C/T TLR4 (Thr399Ile) polymorphisms\udare associated with the susceptibility to pulmonary tuberculosis in the Lur population of Iran.\udMethods: The genotyping of TLR2 and TLR4 polymorphisms accomplished by using PCRrestriction fragment length polymorphism in 100 pulmonary tuberculosis patients and 100\udhealthy control individuals of Lur population of Iran.\udResults: GG genotype frequency of the 753 G/A TLR2 (Arg753Gln) polymorphism decreased\udsignificantly in the patient group as compared with the control group (65% in the patient\udgroup vs. 85% in the control group, P = 0.001 9, odds ratio = 0.328, condidence interval =\ud0.263–0.412). G allele frequency of the 753 G/A TLR2 (Arg753Gln) polymorphism decreased\udsignificantly in the patient group as compared with the control group (70% in the patient group\udvs. 90% in the control group, P = 0.000 8, odds ratio = 0.259, condidence interval = 0.189–\ud0.323).\udConclusions: Our results suggest that 753 G/A TLR2 (Arg753Gln) polymorphism may play a\udrole in the susceptibility to pulmonary tuberculosis in the Lur population of Iran

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here